Granted Patent
Utility
US 6,534,654
· Confirmation No. 2495
PROCESS FOR PREPARING IMIDAZOQUINOLINAMINES
Inventors
John F. Gerster
Woodbury, MN
Kyle J. Lindstrom
Houlton, WI
Attorneys & Agents of Record
Classification
USPC
546/82
C07D401/04
C07D401/14
C07F9/6561
Prosecution
- Examiner
- MORRIS, PATRICIA L
- Art Unit
- 1625
- Customer No.
- 32692
- Docket No.
- 52690US017
- Confirmation No.
- 2495
Publication
- Pub. No.
- US20020188127A1
- Pub. Date
- 2002-12-12
Patent Term Adjustment
-7days
Parent
is a Division of
→
App. 09/678,192
· US 6,437,131
Filed 2000-10-04
· Patented Case
Parent
is a Division of
→
App. 09/375,587
· US 6,150,523
Filed 1999-08-17
· Patented Case
Parent
is a Division of
→
App. 09/061,401
· US 5,998,619
Filed 1998-04-16
· Patented Case
Parent
is a Continuation of
→
App. 08/673,712
· US 5,741,908
Filed 1996-06-21
· Patented Case
Child
is a Division of
→
App. 10/624,014
· US 6,897,314
Filed 2003-07-21
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Child
is a Division of
→
App. 10/352,606
· US 6,613,902
Filed 2003-01-28
· Patented Case
Child
is a Division of
→
App. 10/360,210
· US 6,624,305
Filed 2003-02-06
· Patented Case
Child
is a Division of
→
App. 10/974,258
· US 7,026,482
Filed 2004-10-27
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
NOTICE OF SUCCESSION OF AGENCY
Recorded 2015-01-09
SECURITY AGREEMENT
Recorded 2013-04-24
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2011-12-13
SECOND LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-05-11
RELEASE OF FIRST LIEN SECURITY AGREEMENT IN PATENTS
Recorded 2007-05-10
RELEASE OF SECOND LIEN SECURITY AGREEMENT IN PATENTS
Recorded 2007-05-10
FIRST LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-05-10
SECOND LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-03-23
FIRST LIEN GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS AND TRADEMARKS
Recorded 2007-03-21
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2007-02-08
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,534,654
- App. No.
- 10/180,678
- Filed
- 2002-06-26
- Granted
- 2003-03-18
- Pub. No.
- US20020188127A1
- Examiner
- MORRIS, PATRICIA L
- Art Unit
- 1625
- PTA
- -7 days
External Links